The POC (point-of-care) diagnostics market stands at about $18.8 billion globally, according to recent market trends, and is expected to grow by a third to $24.1 billion this year and projected to explode by 2024 to $46.7 billion. The main driver for these highly optimistic forecasts is the surge in healthcare technology demand brought on by the
New DARPA-Funded Tech Promises to Diagnose COVID-19 Through Implantable Biochip
A new mRNA diagnostic tool developed at Stanford University and funded by BARDA and DARPA is bringing implantable biochip technology closer to reality.